Indications |
Oral Depression Adult: 12.5 mg tid. Elderly: Dose reduction to total daily dose of 25 mg. Renal impairment: Reduce total daily dose to 25 mg/day. Special Populations: Patients with renal impairment: Total daily dose of 25 mg daily. No dose modification in patients with chronic alcoholism or cirrhosis. |
Contraindications |
Childn <15 yrs. Pregnancy and lactation. |
Warnings / Precautions |
General anaesthesia; tasks requiring mental alertness. Avoid abrupt withdrawal, dosage to be decreased gradually over 7-14 days. |
Adverse Reactions |
Abdominal pain, fatigue, nausea, constipation, lack of appetite, insomnia, drowsiness, palpitations, muscular or joint pain, headache, vertigo, tremour, dry mouth, hepatitis (rare) |
Overdose Reactions |
Gastric lavage followed by symptomatic treatment and monitoring of CV, respiratory, metabolic and renal function. |
Drug Interactions |
Potentially Fatal: Avoid concurrent admin with MAOI, start tianeptine 2 wk after discontinuation from MAOI. See Below for More tianeptine Drug Interactions |
Food Interactions |
Decreased absorption with alcohol. |
Mechanism of Actions |
Tianeptine exerts its antidepressant action by increasing the presynaptic re-uptake of serotonin. |
Administration |
Should be taken on an empty stomach. (Take before main meals.) |
Storage Conditions |
Oral: Store below 30°C. |
ATC Classification |
N06AX14 - tianeptine ; Belongs to the class of other antidepressants. |
Storage |
Oral: Store below 30°C. |
Available As |
|
Tianeptine
Post Review about Tianeptine Click here to cancel reply.
Tianeptine Containing Brands
Tianeptine is used in following diseases
Drug - Drug Interactions of Tianeptine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.